Učitavanje...
PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation
Cholangiocarcinoma (CCA) is a highly malignant tumor with resistance to radiotherapy alone. Olaparib, a highly potent poly(ADP‐ribose) polymerase (PARP) inhibitor, has been shown to sensitize many types of tumor to radiotherapy. However, the effect of olaparib, either as monotherapy or as combinatio...
Spremljeno u:
| Izdano u: | Cancer Med |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5911590/ https://ncbi.nlm.nih.gov/pubmed/29479816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1318 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|